Oct 13 (Reuters) - Prometic Life Sciences Inc PLI.TO
* Prometic announces FDA acceptance of its Biologics License Application for Plasminogen (Ryplazim)
* Prometic Life Sciences Inc - prescription Drug User Fee Act (PDUFA) action date is set for April 14, 2018